Cart
sales@molnova.com
ROCK2-IN-10
CAS No. 1072906-07-0
ROCK2-IN-10( —— )
Catalog No. M37666 CAS No. 1072906-07-0
Benzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | Get Quote |
|
| 5MG | 265 | Get Quote |
|
| 10MG | 387 | Get Quote |
|
| 25MG | 591 | Get Quote |
|
| 50MG | 789 | Get Quote |
|
| 100MG | 1035 | Get Quote |
|
| 200MG | 1404 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameROCK2-IN-10
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences.
-
DescriptionBenzenamine, 2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)- is a useful organic compound for research related to life sciences. The catalog number is T9797 and the CAS number is 1072906-07-0.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1072906-07-0
-
Formula Weight246.31
-
Molecular FormulaC13H18N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN1=CC(=CN1)C=2C=CC(N)=C(OCCN(C)C)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Levobunolol hydrochl...
Levobunolol hydrochloride is a non-selective beta-blocker and is used topically to manage glaucoma.
-
Milatuzumab
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
-
4-Methylumbelliferyl...
4-Methylumbelliferyl-β-D-Glucopyranoside is used in the GCase activity assay based on the catalytic hydrolysis of 4-methylumbelliferyl β-D-glucopyranoside that releases the highly fluorescent 4-methylumbelliferyl (4-MU).
